Laurus Bio

About Laurus Bio

Laurus Bio operates as an integrated, research-driven biomanufacturing firm with a specialized focus on precision fermentation and recombinant DNA technology. The company originated as Richcore Lifesciences in 2005, founded by Subramani Ramachandrappa and Rajesh Krishnamurthy in Bengaluru, India. Ramachandrappa, a serial entrepreneur in the biotech industry and an alumnus of the Indian School of Business, had prior experience in new product development at Biocon. In November 2020, Laurus Labs acquired a 72.55% majority stake in Richcore Lifesciences for ₹246.7 crores, which marked Laurus Labs' strategic entry into the biologics and biotechnology sectors. Following the acquisition, Richcore was renamed Laurus Bio, with Ramachandrappa initially continuing to lead management and operations before moving on to found Fermbox Bio.

The firm's business model encompasses two primary streams: producing its own proprietary products and offering Contract Development and Manufacturing Organization (CDMO) services. Laurus Bio engineers microbes to serve as "cell factories" for manufacturing animal-origin-free (AOF) recombinant proteins, growth factors, and cell-culture media supplements. These products are critical inputs for clients in the biopharmaceutical, stem cells and regenerative medicine, vaccine and biological drug manufacturing, and the burgeoning cultured meat industries. This AOF approach provides a safer, virus-free, and more sustainable alternative to traditional animal-derived products.

As a CDMO, Laurus Bio provides its deep expertise in microbial precision fermentation to other biomanufacturers and novel protein companies. The service portfolio covers the entire value chain, from initial clone development, strain engineering, and bioprocess development to pilot-scale and large-scale commercial manufacturing. This allows clients to outsource complex bioprocesses and scale their production efficiently. The company operates state-of-the-art R&D and cGMP-certified manufacturing facilities in Bengaluru, a major biotechnology hub, which provides access to skilled talent and a robust supply chain.